Mode
Text Size
Log in / Sign up

Association of MTHFR C677T Polymorphism with Risk of Lacunar InfarctionGenetic variation linked to increased risk of lacunar infarction

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
MTHFR C677T polymorphism shows association with lacunar infarction risk, but results lose significance after bias adjustment.

This meta-analysis investigated the relationship between the MTHFR C677T genetic polymorphism and the incidence of lacunar infarction. Analyzing a cohort of 5,097 individuals, including 1,598 cases and 3,499 controls, the study evaluated several genetic models to determine the risk profile associated with specific genotypes in patients experiencing small vessel strokes.

Statistical analysis revealed significant associations across multiple genetic models. The recessive model (TT vs. CT + CC) showed an odds ratio of 1.36 (95% CI [1.05, 1.77]), while the dominant model (TT + CT vs. CC) yielded an OR of 1.22 (95% CI [1.05, 1.41]). The allelic model (T vs. C) and the homozygous contrast (TT vs. CC) also demonstrated statistically significant increased risks with odds ratios of 1.19 and 1.45, respectively.

However, the clinical reliability of these findings is tempered by several methodological limitations. A primary concern is the use of unadjusted crude genotype data, which fails to account for critical confounding variables such as existing vascular disease or nutritional status (e.g., folate levels). Furthermore, the pooled estimates combined distinct lacunar phenotypes, potentially masking specific clinical nuances.

Crucially, the application of a trim-and-fill method to address publication bias resulted in the loss of statistical significance across the primary outcomes. This suggests that the initial findings may have been influenced by the selective reporting of positive results in the included studies. Consequently, the evidence base for this association is considered very low certainty according to the GRADE framework. From a clinical perspective, these results do not currently support the use of routine MTHFR genotyping as a tool for risk assessment or management of lacunar infarction. While genetic markers can provide insights into metabolic pathways, the lack of robust, adjusted data means that current practice should remain focused on established cardiovascular risk factors and lifestyle interventions.

In conclusion, while certain genotypes appear associated with increased risk in raw data, the impact of publication bias and potential confounding factors necessitates caution. Clinicians should not interpret these findings as a basis for routine genetic screening or personalized intervention strategies at this stage of clinical evidence.

How this fits prior evidence

This meta-analysis extends prior coverage by examining a specific genetic polymorphism in lacunar infarction. It confirms the association between MTHFR C677T and increased risk, with ORs ranging from 1.19 to 1.45, but contrasts with the more robust findings on retinal vascular features (7,277 participants) by showing that the association is not robust to publication bias adjustment. It also addresses a gap by focusing on genetic risk, whereas prior coverage focused on antiplatelet modification and retinal features. However, the very low certainty and loss of significance after trim-and-fill adjustment temper the clinical relevance.

Stroke is a serious medical event that can change a person's life in an instant. One specific type of stroke, called lacunar infarction, happens when blood flow is blocked in the very small deep parts of the brain. For people living with these conditions, understanding what might contribute to their risk is a major part of long-term health management. This research looks at whether a specific genetic variation, known as the MTHFR C677T polymorphism, plays a role in who develops these types of strokes.

To investigate this, researchers performed a meta-analysis, which means they combined and analyzed data from many different studies. They looked at a large group of over 5,000 people, including nearly 1,600 cases of lacunar infarction and about 3,500 healthy individuals. The goal was to see if the presence of the T allele (a specific part of the MTHFR gene) showed a consistent link to stroke risk across different groups.

The results showed that people with certain versions of this gene—specifically those with the TT genotype or even just one T allele—had a higher risk of lacunar infarction compared to those without it. For example, the study found an increased risk for those with the TT version and also for those carrying at least one copy of the variant. However, there is a very important catch in these numbers. When the researchers adjusted for publication bias (the tendency for only positive results to be published), the statistical significance of these findings disappeared.

It is important not to jump to conclusions based on this single study. The evidence is currently considered to have very low certainty. Because the data used were often unadjusted, other factors like a person's diet, vitamin levels, or general heart health could be influencing the results instead of just the genes. Additionally, because some subgroups had small numbers of participants, it was hard to draw firm conclusions for everyone.

What does this mean for you right now? While the link between this gene and stroke risk is interesting for scientists, it does not change how doctors treat patients today. Currently, there is no recommendation to perform routine genetic testing for MTHFR just to assess the risk of lacunar infarction. For now, the best way to manage stroke risk remains following standard medical advice regarding blood pressure, lifestyle, and other known health factors.

What this means for you:
A genetic marker may be linked to higher stroke risk, but evidence is currently weak and not used for routine testing.

Study Details

Study typeMeta analysis
Sample sizen = 5,097
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
BACKGROUND: The association between the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and lacunar infarction (LI) remains inconclusive. METHODS: The literature retrieval encompassed PubMed, EMBASE, Cochrane Library, China National Knowledge Infrastructure, and Wanfang (inception - March 2026). Case-control studies that reported genotype frequencies of MTHFR C677T (CC, CT, and TT) in LI patients and controls were included. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) for 5 genetic models were calculated using random/fixed-effects models in Stata 13.0. Prespecified exploratory subgroup analyses were conducted by ethnicity and symptom status. Four methodological sensitivity analyses assessed the robustness of findings by restricting analyses to studies with magnetic resonance imaging (MRI) only versus CT/MRI, Trial of Org 10172 in Acute Stroke Treatment classification versus radiological criteria, Hardy-Weinberg equilibrium-compliant controls, and Newcastle-Ottawa Scale score ≥ 7. Meta‑regression, heterogeneity (I2), and publication bias (Begg/Egger tests with trim‑and‑fill) were also performed. RESULTS: Twelve studies comprising 5097 participants (1598 cases/3499 controls) were included. Significant associations were observed in 4 genetic models: recessive (TT vs CT + CC): OR = 1.36, 95% CI = 1.05 to 1.77; dominant (TT + CT vs CC): OR = 1.22, 95% CI = 1.05 to 1.41; allelic model (T vs C): OR = 1.19, 95% CI = 1.07 to 1.33; and homozygous contrast (TT vs CC): OR = 1.45, 95% CI = 1.11 to 1.89. Exploratory subgroup analyses, limited by small numbers of studies in several strata, suggested stronger associations in Asian populations and symptomatic lacunar stroke; these findings are underpowered and should be interpreted with caution. Sensitivity analyses restricting to MRI‑only studies, Trial of Org 10172 in Acute Stroke Treatment‑defined cases, Hardy-Weinberg equilibrium‑compliant controls, or higher‑quality studies (Newcastle-Ottawa Scale ≥ 7) produced results broadly consistent with the primary findings. However, significant publication bias was detected, and all pooled ORs decreased and lost statistical significance after trim‑and‑fill adjustment. CONCLUSION: The initially observed association between MTHFR C677T and LI was no longer significant after trim‑and‑fill adjustment for publication bias. All analyses used unadjusted crude genotype data, so residual confounding by vascular and nutritional factors cannot be excluded, and the pooled estimate combined distinct lacunar phenotypes. A formal assessment using the Grading of Recommendations Assessment, Development and Evaluation framework showed very low certainty of evidence. Routine MTHFR genotyping for LI risk assessment is therefore not currently supported, and further rigorous studies are warranted.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.